Bioventus Investor
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely.
Technology:
Predictive Medicine
Industry:
P4 Medicine
Headquarters:
Durham, North Carolina, United States
Founded Date:
2012-01-01
Employees Number:
251-500
Investor Type:
For Profit
Number Of Exits:
1
Acquisitions Number:
1
Investors Number:
7
Total Funding:
545000000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2022-04-26
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership